Modification of hypothalamic-pituitary-adrenocortical activity by serotonergic agents in the rat

Pharmacology

Volumn 55, Issue 2, 1997, Pages 59-65

  Matheson, G Keith ^a   Knowles, Andrew ^a   Gage, Deanna ^a   Michel, Carla ^a   Guthrie, Deanne ^a   Bauer, Christopher ^a   Blackbourne, Jamie ^a   Weinzapfel, Dan ^a  

^a Indiana University School of Medicine Evansville   (United States)

Author keywords

Anxiolytics; Buspirone; Carvotroline; Corticosterone; Dexamethasone; Enciprazine; Gepirone; Hypothalamic pituitary adrenocortical activity; Serotonin; Stress; Tandospirone

Indexed keywords

8 FLUORO 2,3,4,5 TETRAHYDRO 2 [2 (4 PYRIDYL)ETHYL] 1H PYRIDO[4,3 B]INDOLE; BUSPIRONE; CARVOTROLINE; CORTICOSTERONE; DEXAMETHASONE; ENCIPRAZINE; GEPIRONE; SEROTONIN AGONIST; TANDOSPIRONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ADRENAL CORTEX; ANIMALS; BEHAVIOR, ANIMAL; BUSPIRONE; CARBOLINES; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIPERAZINES; PITUITARY GLAND; PYRIDINES; PYRIMIDINES; RATS; SEROTONIN AGONISTS;

EID: 0030863597     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139513     Document Type: Article

References (30)

1. Fuller RW: The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neu-roendocrinol 1992;13:250-270.
2. Van de Kar LD: Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Ann Rev Pharmacol Toxicol 1991;31:289-320.
3. Holsboer F, Barden N: Antidepressants and hypothalamic-pituitarv-adrenocortical regulation. Endocr Rev 1996;17:187-205.
4. Pazos A, Palacios JM: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 1985:346:205-230.
5. 3H]buspironc binding in rat brain by autoradiography; in Tunnicliff G. Eison AS. Taylor DP (eds): Buspirone: Mechanisms and Clinical Aspects. San Diego, Academic Press. 1991. pp 139-148.
6. Aand 5-HTi) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology 1987:45: 305-310.
7. Koenig LI, Meitzer HY, Gudclsky GA: 5-HvdroxytryptamineiA receptor-mediated effects of buspirone. gepirone and ipsapirone. Pharmacol Biochcm Behav 1988:29:711-715.
8. Matheson GK, Gage D, White G, Dixon V, Gipson D: A comparison of the cffcctsof buspirone and diazepam on plasma corticosterone levels in rat. Neuropharmacology 1988:27: 823-830.
9. Matheson GK, Gage-White D. White G, Guthrie D, Rhoades J. Dixon V: The effect of gepirone and l-(2-pyrimidinyl)-pipcrazine on levels of corticosterone in rat plasma. Neuropharmacology 1989:28:329-334.
10. Robinson DS, Aim DR. Shrotriya RC. Mcssins M. Wickramaratne P: Serotonergic anxiolytics and treatment of depression. Psychopathology 1989:22(suppl 1):27-36.
11. Chaoulof TF: Regulation of 5-HT receptors by corticosteroids: Where do we stand? Fundam Clin Pharmacol 1995:9:219-233.
12. Maes M. Meltzer HY, D'Hondt P. Cosyns P, Blockx P: Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psy-choncuroendocrinology 1995:20: 149-167.
13. Fuller RW: Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Be-hav Brain Res 1996;73:215-219.
14. Seletti B. Benkelfal C, Blier P, Ann-able L. Gilbert F. de Montigny C: Serotonini,\ activation by flesinoxan in humans: Body temperature and neuroendocrine responses. Neuropsychopharmacology 1995:13: 93-104.
15. Peroutka SJ: Selective interact ion of novel anxiolytics with 5-hydroxy-tryptaminciA receptors. Biel Psychol 1985;20:971-979.
16. Smith LM. Peroutka SJ: Differential effects of 5-hydroxytryptamir.eu selective drugs on the 5-HT behavioral syndrome. Pharmacol Biochcm Behav 1986;24:1513-1519.
17. Shimizu H, Tatsuno T. Hirose A, Tanaka H. Kumasaka Y, Nakamura M: Characterization of the putative anxiolytic SM-3997 recognition sites in rat brain. Life Sci 1988:42: 2419-2427.
18. Cusack B, Nelson A. Richelson E: Binding of antidepressants to human brain receptors: Focus on newer generation of compounds. Psychopharmacology 1994:114: 559-565.
19. Engel J, Dleeman A. Jakolev V: En-ciprazinc. Drugs Future 1981; 6: 278-279.
20. Abou-Gharbia M. Patel UR. Webb MB. Moyer JA, Andree TH. Muth EA: Antipsychotic activity of substituted y-carbolines. J Med Chem 1987;30:1818-1823.
21. Schweizer E, Rickcls K, Csaralosi I. Londo J. Turner D: A placebo-controlled study of enciprazine in the treatment of generalized anxiety disorder: A preliminary report. Psycho-pharmacol Bull 1990:26:215-217.
22. A receptor responsi-tivity in unipolar depression: Evaluation of ipsapirone-induccd ACTH and cortisol secretion in patients and controls. Biol Psychiatry 1990: 28:620-628.
23. Schlemmcr RF Jr. Davis JM: Evaluation of WY-47791, A gamma-car-boline antipsychotic candidate, in a primate social colony model of psychosis. Soc Neurosci Abstr 1992:18: 549.
24. Tunnicliff G: Molecular basis of buspirone’s anxiolytic action. Pharmacol Toxicol 1991;69:149-156.
25. Linden M. Heimchen H. Muller-Oerlinghausen B: Early phase-11 semi double-blind study of the new alkaline propanolamine derivative enciprazine. Arzneimittelforsch 1988;38:814-816.
26. Aagonists and by 5-HT; and 5-HTj antagonists. Psychoneurocndocri-nology 1995:20:239-257.
27. Carroll BJ, Curtis GC. Mendels J: Neuroendocrine regulation in depression. I. Limbic svstem-adreno-cortical dysfunction. Arch Gen Psychiatry 1976:33:1039-1044.
28. Fuxe K, Wikström A-C. Okret S, Agnati LF. Harfstrand A, Yu Z-Y, Granholm L. Zoli M. Vale W, Gustafsson J-A: Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel-and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985; 117:1803-1812.
29. Reul JMHM. de Kloct ER: Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 1985:117:2505-2511.
30. Maes M. Van Gastel A, Meitzer HY. Cosyns P, Blockx P, Desnyder R: Acute administration of buspirone increases the escape of hypothalam-ic-pituitary-adrenal-axis hormones from suppression by dexaméthasone in depression. Psychoneuroendocrinology 1996:21:67-81.